Tuesday, June 13, 2017

FDA Quietly Bans Another Cheap Cancer Treatment: Intravenous Vitamin C

ORIGINAL LINK

Vitamic%2BC%2Bintravenous.jpg

It would be naive to think that the FDA endeavors to protect the public’s health as its primary focus.  Indeed, that would be a conflict of interest, as it serves its master, the pharmaceutical industry. Has the Food and Drug Administration engineered a shortage of intravenous vitamin C as part of an overall attack on natural and non-toxic approaches to healing that compete with prescription drugs? An analysis by Natural Blaze would suggest that the answer is yes.



via IFTTT